Clinically Precise Pain Relief Targeting Feline Physiology: Robenatail targets the COX-2 enzyme responsible for producing pain-causing prostaglandins at the site of injury or surgery. This targeted inhibition alleviates acute and chronic pain in your feline companion without the systemic side effects associated with non-selective NSAIDs, making it the preferred choice of veterinarians for feline pain management.

Once-Daily Dosing with 24-Hour Sustained Action: Despite its short residence time in the bloodstream, Robenatail accumulates in inflamed tissue exudate and sustains COX-2 inhibition for a full 24 hours after a single oral dose. This convenient once-daily regimen reduces stress for both your feline friend and you, while maintaining consistent analgesic and anti-inflammatory coverage throughout the day.

Gastroprotective Profile Superior to Conventional NSAIDs: By sparing the COX-1 enzyme that maintains the protective gastric mucosal lining, Robenatail significantly reduces the risk of gastrointestinal ulceration and irritation compared to traditional non-selective NSAIDs. This makes it a markedly safer choice for cats, a species known to be particularly vulnerable to NSAID-induced gastrointestinal and renal injury.

Fever Reduction for Faster Recovery: In addition to its analgesic and anti-inflammatory properties, Robenatail exerts antipyretic action by suppressing the prostaglandin-driven hypothalamic fever response. Your feline companion can recover from fever more comfortably and with less systemic strain during illness or post-surgical recuperation.

Renal-Sparing Design for Added Safety: Because Robenatail minimally inhibits COX-1, the enzyme involved in maintaining renal prostaglandins that regulate blood flow to the kidneys, it poses a lower risk of acute renal injury compared to non-selective NSAIDs. Studies have demonstrated its safety even in cats receiving antihypertensive medications and diuretics, provided the animals are adequately hydrated and under veterinary supervision.

India's First USFDA-Approved Oral NSAID for Cats: Robenatail holds the distinction of being the first orally administered NSAID for cats to receive USFDA approval and enter the Indian veterinary market. This regulatory milestone reflects the robust clinical evidence supporting its safety and efficacy, giving both veterinarians and cat parents confidence in its use.

How to Use:

Vivaldis Robenatail Tablets must be administered only under the prescription and supervision of a qualified veterinarian. The veterinarian will determine the appropriate dose based on your cat's body weight, health status, and the condition being treated. The recommended approach is once-daily oral administration, ideally given to a fasted cat or at least 30 minutes before a meal, as food has been shown to reduce bioavailability. Tablets may be administered directly or concealed in a small amount of food if necessary to aid administration. Do not crush, split, or alter the tablet without veterinary guidance. Never administer Robenatail to cats concurrently with other NSAIDs, corticosteroids, or nephrotoxic medications without explicit veterinary approval. Always complete the prescribed course and do not extend the duration of use beyond what your veterinarian has directed. If your feline companion vomits, shows loss of appetite, develops lethargy, or exhibits any change in urination patterns during treatment, discontinue use immediately and contact your veterinarian.

Storage Advice:

Store unopened Vivaldis Robenatail Tablets in a cool, dry place below 25 degrees Celsius, away from direct sunlight and sources of heat or moisture. Do not freeze. Keep the tablets in their original blister packaging until the time of administration to protect them from humidity. Once the blister strip has been opened, use the exposed tablet immediately and do not return it to storage. Keep out of reach of children and pets at all times. Do not use after the best-before date printed on the outer packaging.

About the Brand:

Founded in 2015 by Kunal Khanna in Pune, India, Vivaldis Animal Health is a pioneering companion animal healthcare company committed to bridging the gap between global veterinary science and Indian pet care. Operating under the umbrella of Sun Pharma following its strategic acquisition in 2023, Vivaldis holds collaborations with globally recognised partners including Bioiberica (Spain) and Catalysis (Spain), and brings products that meet international regulatory standards to the Indian market, as evidenced by Robenatail's USFDA-approved status. The company's R&D philosophy centres on introducing evidence-based, clinically validated therapeutics across chronic disease management, advanced pain care, nutraceuticals, and specialty veterinary diets. Vivaldis upholds a purpose-driven approach to companion animal health built on care, credibility, and scientific rigour, which aligns with Animeal's commitment to offering only the highest-quality veterinary solutions to pet parents across India. Discover Vivaldis today.

Disclaimer:

Please note that while Vivaldis Robenatail (Robenacoxib 6 mg) Tablet is formulated with a USFDA-approved active ingredient and is appropriate for adult cats requiring pain, inflammation, or fever management, it is a prescription-only veterinary medicine and must not be purchased, dispensed, or administered without a valid prescription from a licensed veterinarian. This product is not a complete dietary solution and must not be used as a substitute for a proper veterinary diagnosis and treatment plan. The duration of use is strictly limited to the period prescribed by your veterinarian and must not be extended independently. For cats with pre-existing kidney disease, liver disease, cardiac conditions, dehydration, or concurrent use of diuretics or other NSAIDs, consult your veterinarian before introducing this product. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.